Page 12 - HKSEMR2020 Programme book
P. 12
Symposium Lecture (III)
Management of CA Thyroid: Role of RAI (I-131) & Case
Studies
Dr. Sin Ming Chow
Specialist in Clinical Oncology
MBBS, FRCR, FHKCR, FHKAM (Radiology),
Dip. Epidemiology and Applied Statistics (CUHK), MD (HK)
Thyroid cancer is the most common endocrine cancer in Hong Kong. We have a good experience
in treating the disease with radioactive iodine (I-131). Radioactive iodine plays a dual role: killing the
cancer cells and reducing relapses, assisting follow-up via checking serum thyroglobulin.
In this lecture, I will discuss the indications, procedures, and potential benefits and complications of I-131
treatment. Cases will be presented to best illustrate the usefulness.
10
